Browse our full range of pharmaceutical-grade research peptides and peptide blends. All products include a Certificate of Analysis.
Multi-compound research formulas for combined pathway investigation
Wolverine Stack 10mg is a fixed-ratio research blend containing BPC-157 5mg and TB-500 5mg in one freeze-dried vial. LabDoc report LD-ZACL records 99.79% whole-vial HPLC purity, LC-MS confirmation of both compounds and per-compound content results. The page includes a blend breakdown, source-backed research context, an eight-step photo reconstitution guide and a component-by-component BAC water chart.
Muscle Blend 10mg is a two-peptide research vial labelled with CJC-1295 NO DAC (5mg) and Ipamorelin (5mg). LabDoc report LD-MQQ4 records 99.45% HPLC purity for the whole vial, with both compounds confirmed by LC-MS.
KLOW Blend 80mg combines 50mg GHK-Cu with 10mg each of BPC-157, TB-500 and KPV in one fixed-ratio research vial. LabDoc report LD-E6HW confirms all four identities by LC-MS and records 99.47% HPLC purity for the tested sample.
Showing all 33 results
BPC-157 10mg is a synthetic 15-amino-acid peptide supplied as freeze-dried research material.
TB-500 10mg is a thymosin beta-4 fragment research vial. The name needs careful reading: the analytically identified TB-500 fragment is Ac-LKKTETQ, while much of the published wound and migration literature used full-length thymosin beta-4, a different 43-amino-acid material. This sample is backed by LabDoc report LD-FTNC for LC-MS identity, 99.49% HPLC purity and 9.47 mg measured content.
CJC-1295 NO DAC 10mg is a nominal 10 mg Modified GRF (1-29) research vial, also called Mod GRF 1-29. It is distinct from albumin-binding, long-acting CJC-1295 with DAC. LabDoc report LD-AYN4 records LC-MS identity confirmation, 99.38% HPLC purity and 9.13 mg measured content for the tested sample.
Ipamorelin 10mg is a synthetic pentapeptide studied at the growth-hormone secretagogue receptor, also called the ghrelin receptor. This 10mg vial is supplied for in-vitro research only. It has no product-specific LabDoc report; see the Quality page for available documentation.
Melanotan II 10mg is a cyclic melanocortin research peptide examined in pigmentation and receptor-signalling studies. This vial is supported by LabDoc report LD-VMH4 for identity, purity and content, with a photo reconstitution guide and BAC water concentration chart.
GHRP-6 10mg is a synthetic hexapeptide supplied for in-vitro ghrelin-receptor and growth-hormone-secretagogue pathway research. The vial label states 10 mg and 99% purity.
Retatrutide 10mg is a freeze-dried “Triple G” peptide that activates the GLP-1, GIP and glucagon receptors, independently lab tested and LabDoc verified for identity, purity and content.
Retatrutide 20mg is a larger-quantity vial of the same GLP-1, GIP and glucagon receptor research peptide as Retatrutide 10mg. This vial has its own LabDoc report, LD-M2QV: LC-MS identity confirmed, 99.7% HPLC purity and 19.70mg measured content. Peak Peptides Australia supplies this material for in-vitro research only.
PT-141 10mg (bremelanotide) is a freeze-dried cyclic melanocortin peptide for MC3R, MC4R and central nervous system signalling research. This nominal 10mg research vial is backed by LabDoc report LD-YZY4 for LC-MS identity, HPLC purity and measured content.
Semax 10mg is a freeze-dried synthetic heptapeptide investigated in neurotrophin signalling, BDNF expression and TrkB-related research. LabDoc report LD-Z6HZ confirms identity by LC-MS and records 99.69% HPLC purity in the tested sample.
Selank 10mg is a nominal freeze-dried synthetic heptapeptide research vial based on tuftsin. LabDoc report LD-866B records confirmed LC-MS identity, 98.27% HPLC purity and 9.16mg measured content for its submitted sample.
HCG 5000 IU is a labelled human chorionic gonadotropin research vial for LH/CG receptor and gonadotropin-signalling work. It is a two-subunit glycoprotein hormone, not a short synthetic peptide. Peak Peptides Australia supplies this material for in-vitro research only. The Quality page records Janoshik Task #135353 at 4,556 IU.
NAD+ 1000mg is nicotinamide adenine dinucleotide in its oxidised form: a coenzyme rather than a peptide for cellular redox and NAD-dependent enzyme research. The amber glass vial label identifies 1000 mg nominal content and 99% Purity. LabDoc report LD-QCYH records LC-MS-confirmed identity, 98.37% HPLC purity and 938.49mg measured content. A photo-led preparation guide and BAC water concentration chart explain the 3 mL, 5 mL and 10 mL calculation options for laboratory work. Peak Peptides Australia supplies NAD+ for in-vitro research only.
GHK-Cu 50mg is a blue, freeze-dried copper-peptide research vial containing the glycyl-histidyl-lysine copper complex. It is independently tested by LabDoc for LC-MS identity, HPLC purity and content, with a photo preparation guide and BAC water concentration chart below.
MOTS-C 10mg is a freeze-dried, 16-amino-acid mitochondrial-derived peptide for in-vitro research into cellular energy signalling and metabolic stress. This 10 mg research vial is supported by LabDoc report LD-X67V for identity, purity and content.
Tirzepatide 10mg is a freeze-dried, dual GIP/GLP-1 receptor agonist research peptide.
ARA 290 10mg (cibinetide) is a lyophilised, erythropoietin-derived 11-amino-acid peptide used in innate repair receptor research. LabDoc report LD-24XK records confirmed identity, 99.3% HPLC purity and 9.47mg measured content for its tested sample.
Thymosin Alpha-1 10mg is a freeze-dried, 28-amino-acid peptide also called Tα1 or thymalfasin. It is examined in immune-signalling research involving dendritic cells, T cells, natural-killer cells and Toll-like-receptor pathways. This vial is backed by LabDoc report LD-J82K, which records confirmed LC-MS identity, 99.67% HPLC purity and 9.4mg measured content.
Tesamorelin 10mg is a synthetic growth hormone-releasing hormone (GHRH) analogue for pituitary-signalling research. This freeze-dried research sample is supported by a LabDoc report for identity, purity and content.
KPV 10mg is a freeze-dried Lys–Pro–Val tripeptide: the three-amino-acid C-terminal sequence of alpha-MSH. The supplied nominal 10 mg vial is independently documented by LabDoc for identity, purity and content.
SS-31 10mg is freeze-dried elamipretide, a mitochondria-targeted tetrapeptide used for in-vitro work on cardiolipin-containing inner mitochondrial membranes. LabDoc report LD-HAFB records LC-MS-confirmed identity, 99.52% HPLC purity and 9.51mg measured content.
MOTS-C 20mg is a larger labelled quantity of the same 16-amino-acid mitochondrial signalling peptide supplied as lyophilised research material. This vial has its own LabDoc report, LD-WPTB, recording confirmed LC-MS identity, 99.49% HPLC purity and 18.14mg measured content in the submitted sample. Peak Peptides Australia supplies it for in-vitro research only.
DSIP 10mg is a lyophilised delta sleep-inducing peptide research vial containing a defined nine-amino-acid sequence. This supplied sample is backed by LabDoc report LD-H89L, which confirms identity by LC-MS, records 99.45% HPLC purity and measures 9.22mg content. The page includes a photo reconstitution guide, BAC water concentration chart and clear research context.
IGF-1 LR3 1mg is a freeze-dried Long R3 IGF-I research vial for IGF-system and cell-signalling work. Manufacturer-grade Long R3 instructions specify 0.Peak Peptides Australia supplies this material for in-vitro research only.
Sermorelin 10mg is a GHRH(1-29)-NH2 research peptide for examining anterior-pituitary and growth-hormone signalling.
Epithalon (Epitalon) 10mg is a lyophilised AEDG tetrapeptide studied in telomere biology and circadian-signalling research. This batch is documented by LabDoc for identity, purity and content.
SLU-PP-332 5mg is a synthetic small-molecule pan-ERR agonist for in-vitro research — it is not a peptide. LabDoc LD-ZLZU confirmed its identity by LC-MS with 99.6% HPLC purity. It is dissolved in DMSO first, then diluted with BAC water.
AOD 9604 10mg is a lyophilised modified hGH-fragment research peptide, supplied with acidic solution for this product format. LabDoc report LD-9KXJ records LC-MS identity confirmation, 98.96% HPLC purity and 9.13mg content for the submitted sample.
Oxytocin 10mg is a nine-amino-acid neuropeptide hormone research material for studying the oxytocin receptor (OXTR), neuroendocrine signalling and peptide structure. LabDoc report LD-AKXA confirms identity by LC-MS, 99.68% purity by HPLC and 9.5mg measured content for the tested vial.
Cagrilintide 5mg is a long-acting amylin analogue also known as AM833. This freeze-dried research vial is supported by LabDoc report LD-5S5D, which confirms identity by LC-MS, 99.07% purity by HPLC and 4.49 mg tested content.
PNC-27 10mg is a nominal-quantity, p53-derived synthetic peptide supplied for in-vitro laboratory research only. Published studies examined its p53-derived HDM-2/MDM2-binding segment, membrane residency sequence and membrane-associated effects in selected cell models.
PE-22-28 10mg is a spadin-derived synthetic heptapeptide studied in laboratory TREK-1 potassium-channel experiments. LabDoc report LD-UVDL records LC-MS-confirmed identity, 99.68% HPLC purity and 9.2mg measured content.
Bacteriostatic Water 10mL, often called BAC water, is a sterile-water accessory with a listed 0.9% benzyl alcohol preservative. It is used as a diluent for compatible research materials, not as a peptide.
Scientific context, labelled kit formats and documentation for our two Shop-only HGH research kits. Expand either overview to read the research information. These kits have no separate product-page address.
HGH 191AA research kit
The HGH 191 Kit (120IU) is a laboratory research kit described as 10 vials of HGH 191AA at a nominal 12IU per vial, for a nominal 120IU total, supplied with bacteriostatic water. Its stated research context is somatotropin receptor-binding and IGF-1 signalling studies. HGH 191AA is also called somatropin: the 191AA label identifies the amino-acid sequence, not a special strength, approval or quality category. Buy HGH 191 Kit 120IU online in Australia for laboratory research through the Shop, subject to stock. This is not a single 120IU vial and it is not a clinical-use claim or a personal-use protocol.
Also referred to in research or catalogue references as HGH 191AA, human growth hormone 191 amino acids, somatropin, HGH 191 Kit 120IU.
The supplied product record describes 10 HGH 191AA vials, each labelled 12IU, plus bacteriostatic water. The nominal arithmetic is 10 × 12IU = 120IU for the kit. The total is a kit quantity, not the stated content of any one vial. No water volume, number of water vials, batch or physical presentation beyond the supplied description is stated, so none should be inferred.
HGH 191AA means human growth hormone with a 191-amino-acid sequence. PeptideDosages identifies somatropin as the recombinant form with the sequence of the dominant natural pituitary GH form. In this research context, “HGH 191AA” and “somatropin” are useful identity search terms; they do not turn this Shop-only research kit into a named prescription medicine or establish product-specific quality.
The product record places the kit in somatotropin receptor-binding and IGF-1 signalling pathway research. This is a description of laboratory research areas, not evidence of a result in a person, animal or model. The relationship between growth hormone and IGF-1 is well recognised in endocrine research, but scientific background cannot verify the identity, activity or suitability of a particular untested kit.
An international unit (IU) expresses biological activity; it is not a milligram measure and it is not a syringe-volume marking. Accordingly, the 12IU-per-vial and 120IU-total labels should be read as the supplied nominal IU claims. This page deliberately provides no conversion, dose, concentration or preparation calculation because the kit record does not supply the needed product-specific basis.
HGH 191AA is described as exogenous growth hormone, whereas GHRH analogues such as CJC-1295 NO DAC, Sermorelin and Tesamorelin are researched for pituitary GH-release signalling. GHRP-6 and Ipamorelin are GH secretagogues researched through the ghrelin receptor. Those are different molecular and research categories, not interchangeable names or components of this kit.
The “191AA” notation distinguishes the sequence from the older 192-amino-acid somatrem variant. That nomenclature distinction is useful when reading research references, but it is not a certificate of analysis and does not by itself prove that any vial has a particular identity, purity, sterility, potency or regulatory status.
The product listing says bacteriostatic water is included with the kit. It is an accessory/diluent, not a receptor-active part of HGH research and not evidence of a universal handling method. General reference material notes that bacteriostatic water may be used when product instructions call for it, but its preservative does not establish a reconstituted product’s stability period or remove contamination risk. No storage, mixing or personal-use instructions are provided here.
LabDoc report LD-EBW6 records a Peak Peptides Australia HGH (Somatropin) sample, received 16 October 2026 and tested 21 October 2026, as “Lyophilized Powder (Vial)”. It records a 36 IU label claim, 34.45 IU HPLC content (95.69% of claim, as printed on the report), 99.4% HPLC purity, LC-MS identity confirmed and an overall Pass. No batch identifier is stated. The result covers the tested sample. View the signed report and PDF on the Quality/COA page or check it directly on LabDoc.
LabDoc report LD-26JP records a Peak Peptides Australia HGH sample, received and tested on 20 August 2026, as “Lyophilized Powder (Vial)”. It records 10.98IU HPLC content, 99.9% HPLC purity, LC-MS identity confirmed and an overall Pass. Against the 12IU vial label that is 91.5% of the labelled amount; the report itself prints the measured IU without a separate label-claim line. The result covers the tested vial. View the signed report and PDF on the Quality/COA page or check it directly on LabDoc.
The supplied record describes 10 HGH 191AA vials labelled 12IU each, giving a nominal kit total of 120IU, with bacteriostatic water. It does not state water volume, the number of water vials, a batch, a storage condition or a preparation method.
No. The stated format is 10 separate 12IU vials, not one vial labelled 120IU. The 120IU figure is the nominal total across the kit.
HGH 191AA refers to the 191-amino-acid human growth hormone sequence. Somatropin is the recombinant name used for that sequence in prescription-medicine contexts. The shared sequence terminology does not make this research kit an approved medicine or establish its product-specific quality.
The number denotes amino acids in the growth-hormone sequence. HGH 191AA is distinguished from the older 192-amino-acid somatrem variant. This is an identity-naming distinction, not a claim about quality, activity or suitability.
They are not interchangeable labels. HGH 191AA is described as exogenous growth hormone, while CJC-1295 NO DAC, Sermorelin and Tesamorelin are GHRH analogues researched for GH-release signalling. Ipamorelin is a GH secretagogue researched through the ghrelin receptor. This comparison does not recommend a combination or protocol.
Yes, two. The newest, LabDoc report LD-EBW6 (received 16 October, tested 21 October 2026), records a Peak Peptides Australia HGH sample with a 36 IU label claim, 34.45 IU HPLC content (95.69% of claim), 99.4% HPLC purity, LC-MS identity confirmed and Pass. The earlier report LD-26JP, tested 20 August 2026, records a vial with 10.98IU HPLC content (91.5% of the 12IU vial label), 99.9% HPLC purity, LC-MS identity confirmed and Pass. Both signed reports and PDFs are on the Quality/COA page, and each can be checked at labdoc.org/batch/LD-EBW6 and labdoc.org/batch/LD-26JP.
No. Its inclusion identifies an accessory supplied with the kit; it does not provide a product-specific mixing procedure, storage condition, stability window or personal-use direction. Refer only to applicable approved product documentation and laboratory procedures for the exact material being studied.
Scientific background reference
Science sections summarise the published studies listed above. Test results for this product come from its own lab report.
HGH 191 kit research information
HGH 191 Kit (320IU) is a research kit containing 10 HGH 191 vials labelled at a nominal 32IU each, totalling a nominal 320IU, with bacteriostatic water. HGH 191AA is also called somatropin or human growth hormone (GH); 191AA identifies the amino-acid sequence, not a special strength or quality grade. The water is an accessory, not an active peptide. This overview explains the kit format, terminology and sample-specific analytical record. Supplied strictly for legitimate in-vitro research; not for human or animal use.
Also referred to in research or catalogue references as HGH 191AA, human growth hormone 191 amino acids, somatropin, HGH 191 Kit 320IU.
The kit comprises 10 HGH 191 vials, each labelled at a nominal 32IU, plus bacteriostatic water. It is not one 320IU vial. The water is a diluent accessory, not an HGH analogue, peptide blend or receptor-active ingredient. The product listing does not state a water volume, vial concentration, final preparation volume or protocol.
HGH 191AA is the 191-amino-acid form of human growth hormone. PeptideDosages describes somatropin as the recombinant version whose sequence matches natural pituitary hormone. “191AA”, “HGH 191” and “somatropin” identify the material but do not prove that a vial is an approved medicine or confirm a batch’s quality. The older 192-amino-acid somatrem form is not an alternative name for this kit.
The kit is described for somatotropin receptor-binding and IGF-1 signalling research. IGF-1 is produced primarily by the liver in response to GH stimulation and mediates many GH-related tissue effects. This supports examination of direct GH and downstream IGF-1 observations; it is not a claim of a clinical, performance, body-composition or recovery outcome. Study findings depend on the tested formulation, model and endpoints.
HGH 191AA/somatropin is the growth-hormone sequence itself. It differs from GH secretagogues and GHRH analogues, which are studied for stimulating endogenous GH release. CJC-1295 NO DAC and Ipamorelin are separately listed research compounds, not kit components or interchangeable substitutes. Their quantities and analytical records cannot be transferred to this kit.
International Units (IU) measure biological activity, rather than volume. Here, 32IU is the nominal claim per HGH vial and 320IU is the total across 10 vials. IU is not a millilitre or a syringe marking. The kit label does not state a ready-made concentration or experiment design; laboratory concentration depends on actual content and a validated project-specific method.
LabDoc report LD-5BSF records a Peak Peptides Australia HGH sample, received and tested on 20 August 2026, as “Lyophilized Powder (Vial)”. It records 31.4IU HPLC content, 99.9% HPLC purity, LC-MS identity confirmed and Pass. The published documentation identifies a nominal 32IU submitted vial, so 31.4IU is 98.12% of that claim. These findings apply to the submitted sample, not all 10 vials in every kit.
Identity, purity and content answer different questions. LC-MS supports the submitted sample’s identity; HPLC purity describes its composition; HPLC content reports its IU amount. Neither purity nor Pass establishes pharmaceutical approval, sterility, endotoxin status, biological activity in a particular assay, clinical safety or suitability for administration. LabDoc says the report covers the tested sample only and is not a statement of lawfulness, safety or suitability.
This is a Shop-only kit, not a named prescription somatropin product, delivery device or clinical-trial formulation. Product-specific formulation, handling, storage, stability and disposal instructions for an approved medicine do not automatically apply. No PeptideDosages source for a 10 x 32IU HGH kit was found, and the report provides no universal stability period, water quantity or sterility test.
It identifies the 191-amino-acid form of human growth hormone. Somatropin is recombinant human growth hormone with that sequence. The term does not demonstrate that a vial is an approved medicine or confirm an individual batch.
The product listing specifies 10 HGH 191 vials labelled at a nominal 32IU each, totalling 320IU, with bacteriostatic water. The water is an accessory, not a second active compound. No water volume, concentration or universal preparation method is stated.
No. The kit contains 10 nominal 32IU HGH vials. The 320IU figure is their labelled total and does not state a solution volume or concentration.
No. HGH 191AA/somatropin is the growth-hormone sequence. CJC-1295 NO DAC is a GHRH analogue and Ipamorelin a GH secretagogue. They are different research compounds, are not kit components and are not interchangeable.
LD-5BSF, tested 20 August 2026, records a submitted HGH lyophilised-powder vial with 31.4IU HPLC content, 99.9% HPLC purity, LC-MS identity confirmed and Pass. It identifies a nominal 32IU submitted sample and applies to that sample only, not every vial or later kit.
No. Purity is one analytical result for a submitted sample; identity and IU content are separate findings. The report does not establish sterility, endotoxin status, clinical safety, approval, a universal stability period or suitability for human or animal use.
The Shop-only HGH 191 Kit (320IU) can be ordered online through Peak Peptides Australia when available. Orders dispatch from Victoria via Australia Post Express, with tracking after dispatch. Express delivery is not a next-day guarantee; this is a research-material route, not a pharmacy prescription presentation.
Scientific background reference
Science sections summarise the published studies listed above. Test results for this product come from its own lab report.